Skip to content
My WebMD Sign In, Sign Up

Cancer Health Center

Font Size

Langerhans Cell Histiocytosis Treatment (PDQ®): Treatment - Patient Information [NCI] - General Information About Langerhans Cell Histiocytosis (LCH)

continued...

Certain factors affect prognosis (chance of recovery) and treatment options.

LCH in organs such as the skin, bones, lymph nodes, or pituitary gland usually gets better with treatment and is called "low- risk". LCH in the spleen, liver, or bone marrow is harder to treat and is called "high-risk".

The prognosis (chance of recovery) and treatment options depend on the following:

  • How old the patient is when diagnosed with LCH.
  • How many body systems the disease affects.
  • Whether the disease is found in the liver, spleen, bone marrow, or certain bones in the skull.
  • How quickly the disease responds to initial treatment.
  • Whether the disease has just been diagnosed or has come back (recurred).

In infants up to one year of age, LCH may go away without treatment.

1|2|3
1|2|3

WebMD Public Information from the National Cancer Institute

Last Updated: February 25, 2014
This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information.
Next Article:

Today on WebMD

Building a Support System
Blog
cancer fighting foods
SLIDESHOW
 
precancerous lesions slideshow
SLIDESHOW
quit smoking tips
SLIDESHOW
 
Jennifer Goodman Linn self-portrait
Blog
what is your cancer risk
HEALTH CHECK
 
colorectal cancer treatment advances
Video
breast cancer overview slideshow
SLIDESHOW
 
prostate cancer overview
SLIDESHOW
lung cancer overview slideshow
SLIDESHOW
 
ovarian cancer overview slideshow
SLIDESHOW
Actor Michael Douglas
Article